STRATEC SE
ISIN: DE000STRA555
WKN: STRA55
30 July 2024 09:55AM

EQS-News: STRATEC REPORTS CHANGES IN FINANCE DIVISION

STRATEC SE · ISIN: DE000STRA555 · EQS - Company News
Country: Germany · Primary market: Germany · EQS NID: 1956523

EQS-News: STRATEC SE / Key word(s): Personnel
STRATEC REPORTS CHANGES IN FINANCE DIVISION

30.07.2024 / 09:55 CET/CEST
The issuer is solely responsible for the content of this announcement.


STRATEC REPORTS CHANGES IN FINANCE DIVISION

Birkenfeld, July 30, 2024

STRATEC SE, a leading manufacturer of automation solutions for partners in clinical diagnostics and life sciences, is reporting a change in the composition of its Board of Management.

In agreement with the company, Dr. Robert Siegle, a member of the Board of Management of STRATEC SE, will stand down from his position on the Board of Management and leave the company as of August 31, 2024.

Prof. Dr. Georg Heni, Chairman of the Supervisory Board, thanks Dr. Robert Siegle on behalf of STRATEC SE for his longstanding and successful commitment to the company. During his time as a member of the Board of Management, Dr. Siegle has made a major contribution to the company’s successful development.

Dr. Siegle’s tasks will be performed by Oliver Albrecht, who will act in the capacity of an interim CFO. Oliver Albrecht has a long track record of experience and great expertise in leading finance departments at listed technology companies with an international focus. He was most recently Chief Financial Officer at the listed company SÜSS MicroTec SE from 2019 to 2023.

ABOUT STRATEC
STRATEC SE (www.stratec.com) designs and manufactures fully automated analyzer systems for its partners in the fields of clinical diagnostics and life sciences. Furthermore, the company offers complex consumables for diagnostic and medical applications. For its analyzer systems and consumables, STRATEC covers the entire value chain – from development to design and production through to quality assurance.

The partners market the systems, software, and consumables, in general together with their own reagents, as system solutions to laboratories, blood banks, and research institutes around the world. STRATEC develops its products on the basis of patented technologies.

Shares in the company (ISIN: DE000STRA555) are traded in the Prime Standard segment of the Frankfurt Stock Exchange and are listed in the SDAX select index of the German Stock Exchange.

FURTHER INFORMATION IS AVAILABLE FROM:
STRATEC SE
Jan Keppeler, CFA
Investor Relations, Sustainability & Corporate Communications
Tel: +49 7082 7916-6515
ir@stratec.com
www.stratec.com



30.07.2024 CET/CEST Dissemination of a Corporate News, transmitted by EQS News - a service of EQS Group AG.
The issuer is solely responsible for the content of this announcement.

The EQS Distribution Services include Regulatory Announcements, Financial/Corporate News and Press Releases.
Archive at www.eqs-news.com


Language: English
Company: STRATEC SE
Gewerbestr. 37
75217 Birkenfeld
Germany
Phone: +49 (0)7082 7916 0
Fax: +49 (0)7082 7916 999
E-mail: info@stratec.com
Internet: www.stratec.com
ISIN: DE000STRA555
WKN: STRA55
Indices: SDAX
Listed: Regulated Market in Frankfurt (Prime Standard); Regulated Unofficial Market in Berlin, Dusseldorf, Hamburg, Hanover, Munich, Stuttgart, Tradegate Exchange
EQS News ID: 1956523

 
End of News EQS News Service

1956523  30.07.2024 CET/CEST

fncls.ssp?fn=show_t_gif&application_id=1956523&application_name=news&site_id=boersengefluester~~~ace3d64b-2049-452a-8d18-fbc8044c4b5f

Boersengefluester.de (BGFL) provides an overview of the key figures on sales, earnings, cash flow and dividends to help you better assess the fundamental development of the respective companies. All information is entered manually in our database - the source is the respective annual reports. All estimates for future figures are provided by BGFL.

The most important financial data at a glance
  2018 2019 2020 2021 2022 2023 2024e
Sales1 187,82 214,16 250,10 287,34 274,63 261,91 265,00
EBITDA1,2 35,53 35,60 56,27 66,43 58,07 40,08 42,00
EBITDA-Margin3 18,92 16,62 22,50 23,12 21,15 15,30 15,85
EBIT1,4 15,01 17,19 33,68 48,18 41,14 22,39 25,00
EBIT-Margin5 7,99 8,03 13,47 16,77 14,98 8,55 9,43
Net Profit (Loss)1 8,97 14,41 25,18 39,96 29,22 13,07 14,50
Net-Margin6 4,78 6,73 10,07 13,91 10,64 4,99 5,47
Cashflow1,7 11,95 21,26 31,85 63,47 10,28 19,43 0,00
Earnings per share8 0,75 1,20 2,07 3,28 2,41 1,07 1,20
Dividend per share8 0,82 0,84 0,90 0,95 0,97 0,55 0,70
Quelle: boersengefluester.de and Company information
Explanation

1 in Mio. Euro; 2 EBITDA = Earnings before interest, taxes, depreciation and amortisation; 3 EBITDA in relation to sales; 4 EBIT = Earnings before interest and taxes; 5 EBIT in relation to sales; 6 Net profit (-loss) in relation to sales; 7 Cashflow from operations; 8 in Euro; Source: boersengefluester.de

Auditor: RSM Ebner Stolz

All relevant valuation ratios, dates and other investor information on your share at a glance. Good to know: All data comes from boersengefluester.de and is updated daily. This means you are always up to date. You can get brief explanations of the key figures by moving the cursor or mouse over the relevant field.

INVESTOR-INFORMATION
©boersengefluester.de
Stratec
WKN ISIN Legal Type Marketcap IPO Recommendation Plus Code
STRA55 DE000STRA555 SE 352,58 Mio € 25.08.1998 Halten 8FWCVH7J+C5
* * *
PE 2025e PE 10Y-Ø BGFL-Ratio Shiller-PE PB PCF KUV
17,06 33,24 0,51 16,40 1,56 18,15 1,35
Dividends
Dividend '2022
in €
Dividend '2023
in €
Dividend '2024e
in €
Div.-Yield '2024e
in %
0,97 0,55 0,70 2,41%
Financial calendar
Annual General Meeting Q1-figures Q2-figures Q3-figures Annual press conference
23.05.2025 09.05.2025 19.08.2025 25.10.2024 27.03.2025
Performance
Distance 60-days-line Distance 200-days-line Performance YtD Performance 52 weeks IPO
Last Price (EoD)
+0,69%
29,00 €
ATH 147,40 €
-15,93% -28,24% -36,33% -32,56% +883,05%

Advertising is an important revenue channel for us. But we understand, that sometimes it becomes annoying. If you want to reduce the number of shown ADs just simply login to your useraccount and manage the settings from there. As registered user you get even more benefits.
          Qualitätsjournalismus · Made in Germany © 2024          
The news manufactory

Good luck with all your investments

Founded in 2013 by Gereon Kruse, the financial portal boersengefluester.de is all about German shares - with a clear focus on second-line stocks. In addition to traditional editorial articles, the site stands out in particular thanks to a large number of self-developed analysis tools. All tools are based on a completely self-maintained database for more than 650 shares. As a result, boersengefluester.de produces Germany's largest profit and dividend forecast.

Contact

Idea & concept: 3R Technologies   
boersengefluester.de GmbH Copyright © 2024 by Gereon Kruse #BGFL